Page 2481 - Hematology_ Basic Principles and Practice ( PDFDrive )

2214.e4 Part XII Hemostasis and Thrombosis

162. Robinson S, Bewley S, Hunt BJ, et al: The management and outcome 188. Bates SM, Ginsberg JS: Pregnancy and deep vein thrombosis. Semin
of 18 pregnancies in women with polycythemia vera. Haematologica Vasc Med 1:97, 2001.
90:1477, 2005. 189. Pabinger I, Grafenhofer H, Hyrle PA, et al: Temporary increase in the
163. Tulpule S, Bewley S, Robinson SE, et al: The management and risk for recurrence during pregnancy in women with a history of venous
outcome of four pregnancies in women with idiopathic myelofibrosis. thromboembolism. Blood 100:1060, 2002.
Br J Haematol 142:480, 2008. 190. Macklon NC, Greer IA, Bowman AW: An ultrasound study of ges-
164. Landolfi R, Marchioli R: European Collaboration on Low-dose Aspirin tational and postural changes in the deep venous system of the leg in
in Polycythemia Vera (ECLAP): a randomized trial. Semin Thromb pregnancy. Br J Obstet Gynaecol 104:191, 1997.
Hemost 23:473, 1997. 191. Kerr MG, Scott DB, Samuel E: Studies of the inferior vena cava in late
165. Sadler JE: A revised classification of von Willebrand disease. Thromb pregnancy. Br Med J 1:532, 1964.
Haemost 71:520, 1994. 192. Ginsberg JS, Brill-Edwards P, Burrows RF, et al: Venous thrombosis
166. Foster PA: The reproductive health of women with von Willebrand during pregnancy: leg and trimester of presentation. Thromb Haemost
disease unresponsive to DDAVP: results of an international survey. 67:519, 1992.
Thromb Haemost 74:784, 1995. 193. Cerneca F, Ricci G, Simeone R, et al: Coagulation and fibrinolysis
167. Fausett B, Silver RM: Congenital disorders of platelet function. Clin changes during normal pregnancy: increased levels of procoagulants and
Obstet Gynecol 42:390, 1999. reduced levels of inhibitors during pregnancy induce a hypercoagulable
168. Sié P, Caron C, Azam J, et al: Reassessment of von Willebrand factor state, combined with reactive fibrinolysis. Eur J Obstet Gynecol Reprod
(VWF), VWF propeptide, factor VIII:C and plasminogen activator Biol 73:31, 1997.
inhibitors 1 and 2 during normal pregnancy. Br J Haematol 121:897, 194. De Moerloose P, Amiral J, Vissac AM, et al: Longitudinal study on
2003. activated factors XII and VII levels during normal pregnancy. Br J
169. Chediak JR, Alban GM, Maxey B, et al: von Willebrand’s disease and Haematol 100:40, 1998.
pregnancy: management during delivery and outcome of offspring. Am 195. Brenner B: Haemostatic changes in pregnancy. Thromb Res 114:409,
J Obstet Gynecol 155:618, 1986. 2004.
170. Noller KL, Bowie EJ, Kempers RD, et al: von Willebrand’s disease in 196. Bates SM, Ginsberg JS: How we manage venous thromboembolism
pregnancy. Obstet Gynecol 41:865, 1973. during pregnancy. Blood 100:3470, 2002.
171. Ragni MV, Bontempo FA, Hassett AC: von Willebrand disease and 197. Kearon C, Ginsberg JS, Hirsh J: The role of venous ultrasonography
bleeding in women. Haemophilia 9:313, 1999. in the diagnosis of suspected deep venous thrombosis and pulmonary
172. Kujovich JL: von Willebrand disease and pregnancy. J Thromb Haemost embolism. Ann Intern Med 129:1044, 1998.
3:246, 2005. 198. Hirsh J, Lee AY: How we diagnose and treat deep vein thrombosis.
173. Mannucci PM: Treatment of von Willebrand’s disease. N Engl J Med Blood 99:3102, 2002.
351:683, 2004. 199. McKenna R, Cole ER, Vasan U: Is warfarin sodium contraindicated in
174. James AH: von Willebrand disease. Obstet Gynecol Surv 61:136, the lactating mothers? J Pediatr 103:325, 1983.
2006. 200. Parry RA, Glaze SA, Archer BR: The AAPM/RSNA physics tutorial
175. Milaskiewicz RM, Holdcroft A, Letsky E: Epidural anesthesia and von for residents: typical patient radiation doses in diagnostic radiology.
Willebrand’s disease. Anaesthesia 45:462, 1990. Radiographics 19:1289, 1999.
176. Sage DJ: Epidurals, spinals, and bleeding disorders in pregnancy: a 201. Chan WS, Ray JG, Murray S: Suspected pulmonary embolism in
review. Anaesth Intensive Care 18:319, 1990. pregnancy. Arch Intern Med 162:1170, 2002.
177. DeVore GR, Mahoney MJ, Hobbins JC: Antenatal diagnosis of 202. Kock HJ, Handschin AE: Osteoblast growth inhibition by unfrac-
hemoglobinopathies, hemophilia, von Willebrand’s disease, Duchenne’s tionated heparin and by low molecular weight heparins: an in-vitro
muscular dystrophy, and chronic granulomatous disease by fetal blood investigation. Clin Appl Thromb Hemost 8:251, 2002.
analysis. Clin Obstet Gynecol 7:41, 1980. 203. Greer IA, Nelson-Piercy C: Low-molecular-weight heparins for
178. Mannucci PM, Tuddenham EG: The hemophilias—from royal genes thromboprophylaxis and treatment of venous thromboembolism in
to gene therapy. N Engl J Med 344:1782, 2001. pregnancy: a systematic review of safety and efficacy. Blood 106:401,
179. Yang MY, Ragni MV: Clinical manifestations and management of labor 2005.
and delivery in women with factor IX deficiency. Haemophilia 10:483, 204. Ruiz-Irastorza G, Khamashta MA, Hughes GR: Heparin and osteopo-
2004. rosis during pregnancy: 2002 update. Lupus 11:680, 2002.
180. Centers for Disease Control and Prevention: Report on the Universal 205. Warkentin TE, Levine MN, Hirsh J, et al: Heparin-induced throm-
Data Collection Program (UDC). 4:1, 2002. <www.cdc.gov/ncidod/ bocytopenia in patients treated with low molecular weight heparin or
dastir/Hematology/HDBpubs.htm>. unfractionated heparin. N Engl J Med 332:1330, 1995.
181. Ratnoff OD, Steinberg AG: Chariman’s introductory remarks: detec- 206. Casele HL, Laifer SA, Woelker DA, et al: Changes in pharmacokinetics
tion of the carrier state of classic hemophilia. Ann N Y Acad Sci 240:95, of the low molecular weight heparin enoxaparin during pregnancy. Am
1975. J Obstet Gynecol 181:1113, 1999.
182. Kogan SC, Doherty M, Gitschier J: An improved method for prenatal 207. Tengborn L, Bergqvist D, Matzsch T, et al: Recurrent thromboembo-
diagnosis of genetic diseases by analysis of amplified DNA sequences: lism in pregnancy and puerperium. Am J Obstet Gynecol 160:90, 1989.
application to hemophilia A. N Engl J Med 317:985, 1987. 208. Brill-Edwards P, Ginsberg J, Gent M, et al: Safety of withholding
183. Russell Z, Riconda D, Pollack L, et al: Thrombosis in a pregnant antepartum heparin in women with a previous episode of venous
hemophilia A carrier after intrapartum recombinant factor VIII. Obstet thromboembolism. N Engl J Med 343:1439, 2000.
Gynecol 105:875, 2005. 209. Robertson L, Wu O, Langhorne P, et al: Thrombophilia in pregnancy:
184. Michaud JL, Rivard GE, Chessex P: Intracranial hemorrhage in a a systematic review. Br J Haematol 132:171, 2006.
newborn with hemophilia following elective cesarean section. Am J 210. Kaandorp SP, Goddijn M, van der Post JA, et al: Aspirin plus heparin
Pediatr Hematol Oncol 13:473, 1991. or aspirin alone in women with recurrent miscarriage. N Engl J Med
185. Greer IA, Lowe GD, Walker JJ, et al: Hemorrhagic problems in 362:1586, 2010.
obstetrics and gynecology in patients with congenital coagulopathies. 211. Robertson L, Wu O, Langhorne P, et al: Thrombophilia in pregnancy:
Br J Obstet Gynaecol 98:909, 1991. a systematic review. Br J Haematol 132:171, 2006.
186. Egbring R, Kroniger A, Seitz R: Factor XIII deficiency: pathologic 212. Carion R, Zobelem GT, Soria C, et al: Inhibitor of protein C activation
mechanisms and clinical significance. Semin Thromb Hemost 22:419, by endothelial cells in the presence of lupus anticoagulant (letter). N
1996. Engl J Med 314:1193, 1986.
187. Bates SM, Greer IA, Hirsh J, et al: Use of antithrombotic agents during 213. Malia RG, Kitchen S, Greaves M, et al: Inhibition of activated protein
pregnancy: the Seventh ACCP Conference on Antithrombotic and C and its cofactor protein S by antiphospholipid antibodies. Br J
Thrombolytic Therapy. Chest 126(3 Suppl):627S, 2004. Haematol 76:101, 1990.